🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Arjun Acharya

Texas A&M University

ORCID: 0000-0002-2506-900X
MedicineNursingImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo”.

An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo

Cell Reports(2024)10.1016/j.celrep.2024.114929
N/A
0.398DataRank · unranked
10 citations

Su Tang, Xuelin Bian, Maloy Kumar Parai, Inna V. Krieger, Armando Flores +27 more

Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice

Science(2020)10.1126/science.aaz8899
N/A
0DataRank · unranked
191 citations

Shivatheja Soma, Sai Yuan, Andres Silva, Mohammad Zulkifli, Thomas Snavely +12 more

Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c01586
N/A
0DataRank · unranked
37 citations

Peter C. Ray, Fabio Zuccotto, Jorge Hernández, Anup Aggarwal, Claire J. Mackenzie +35 more

An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo

UNC Libraries(2024)10.17615/wwq1-b853
N/A
0DataRank · unranked
0 citations

Maloy Kumar Parai, Timothy P. Sheahan, Jeremy P. Wood, Bian, Xuelin, Inna V. Krieger +27 more